Evidence map›Paper›PMID 31628053›Full record

ArticleImmunity2019

Butyrophilin-like 3 Directly Binds a Human Vγ4

Carrie R Willcox, Pierre Vantourout, Mahboob Salim, Iva Zlatareva, Daisy Melandri, Leonor Zanardo, Roger George, Svend Kjaer, Mark Jeeves, Fiyaz Mohammed and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 165 citations in OpenAlex.

  1. γδ T cells in colorectal and liver cancer.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  9. Article
  10. International journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Carrie R WillcoxInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Pierre VantouroutPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Mahboob SalimInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Iva ZlatarevaPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Daisy MelandriPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
Leonor ZanardoInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK; Faculty of Medicine, University of Tours, Tours, France.
Roger GeorgeStructural Biology Team, The Francis Crick Institute, London, UK.
Svend KjaerStructural Biology Team, The Francis Crick Institute, London, UK.
Mark JeevesHenry Wellcome Building for NMR, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Fiyaz MohammedInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK.
Adrian C HaydayPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. Electronic address: adrian.hayday@kcl.ac.uk.
Benjamin E WillcoxInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; Cancer Immunology and Immunotherapy Centre, University of Birmingham, Birmingham, UK. Electronic address: b.willcox@bham.ac.uk.
University of Birmingham · GBKing's College London · GBThe Francis Crick Institute · GBUniversité de Tours · FR

Funding

Cancer Research UK FC001093Department of HealthMedical Research Council FC001093Wellcome Trust 099266/Z/12/ZWellcome Trust 106292/Z/14/ZWellcome Trust 208400/Z/17/ZWellcome Trust FC001093
6 · The paper itself

Abstract

Butyrophilin (BTN) and butyrophilin-like (BTNL/Btnl) heteromers are major regulators of human and mouse γδ T cell subsets, but considerable contention surrounds whether they represent direct γδ T cell receptor (TCR) ligands. We demonstrate that the BTNL3 IgV domain binds directly and specifically to a human Vγ4

Indexed as

Amino Acid SequenceAnimalsAntigensButyrophilinsCell LineClonal Selection, Antigen-MediatedEpitopesGerm CellsHumansImmunoglobulin Variable RegionLigandsMiceProtein BindingProtein Interaction Domains and MotifsReceptors, Antigen, T-Cell, gamma-deltaStructure-Activity RelationshipAntigensButyrophilinsEpitopesImmunoglobulin Variable RegionLigandsReceptors, Antigen, T-Cell, gamma-deltabutyrophilincomplementarity determining regiongamma delta T cellligandselectionT cell receptor

Identifiers

PMID31628053
PMCPMC6868513
OpenAlexW2980596624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.